
Longitude Prize on ALS
6.8K posts

Longitude Prize on ALS
@longitude_prize
Join us in bringing AI to the fight against ALS, the most common form of motor neurone disease. Learn more at our website, and follow us for updates.











"The steps the country takes now could shape its ability to respond in the future." In his latest opinion piece for @DeccanHerald, CCAMP Director-CEO @Taslimarif reflects on India’s AI-based drug discovery, research into diseases of ageing, and the impact of the Longitude Prize on ALS. Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects motor neurons, causing the brain to gradually lose its ability to control muscles and impacting mobility, speech, and breathing. It affects approximately 2–3 people per 100,000 individuals worldwide. Read now: deccanherald.com/opinion/harnes… Dr. Taslimarif Saiyed is a jury member on the @longitude_prize, the £7.5M global challenge for ALS treatment technologies. Apply now: als.longitudeprize.org @DrJitendraSingh @DBTIndia @rajesh_gokhale @IndiaDST @karandi65 @BIRAC_2012 @AIMtoInnovate @NITIAayog @NIMHANS_BLR @kris_sg @NCBS_Bangalore @DBT_inStem @DBT_NBRC @aiims_newdelhi @aiims_jodhpur @iitmadras @iiscbangalore @startupindia @ITBTGoK @Ktech_biotech @startupindia






🧠 The #LongitudePrizeOnALS is now live! This £7.5M challenge invites innovators across #biotech, #AI, and #data science to help accelerate #ALS treatment discovery. Join us in bringing AI to the fight against ALS. Learn more: bit.ly/442yOqy #LPALS #MND



Summit day is almost here! 🙌 Join us this Friday for the ALS TDI Summit — a free conference sharing the latest breakthroughs in ALS research. There’s still time to register to attend virtually 🌍 👉 fundraise.als.net/alssummit

⏰ 2 months to go until applications close for the £7.5 million Longitude Prize on ALS. You could help transform treatment for neurodegenerative diseases like hashtag #ALS, the most common form of motor neurone disease (#MND). Learn more: bit.ly/4mlzSg5






